Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 5.660

+2.4%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: richardred who wrote (2274)	7/17/2010 2:47:23 PM
From: richardred	Read Replies (1) of 7252

MRX-Oldie Would-be acquirer Medicis finds itself target of $2.2B Mentor offer.(Medicis Pharmaceutical)(Merry X-Ray acquires SourceOne Healthcare Technologies)(BioVeris in licensing and research agreement with Jewish General Hospital of Montreal) Medical Device Week \| November 22, 2005 \| JOHNSON, HOLLAND \| COPYRIGHT 2005 AHC Media LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright Ads by Google Would-be acquirer Medicis finds itself target of $2.2B Mentor offer By HOLLAND JOHNSON Medical Device Daily Associate Managing Editor Medicis Pharmaceutical (Scottsdale, Arizona), currently actively seeking to buy breast implant maker Inamed (Santa Barbara, California), found itself over the weekend the target of an acquisition offer by Mentor (Santa Barbara, California). Mentor's offer to acquire Medicis came less than a week after Medicis was outbid by Allergan (Irvine, California), both companies seeking to acquire Inamed. That competition perhaps emboldened Mentor to make its proposal to acquire Medicis. In the latest chapter of what is turning into a soap opera whose plot revolves around a scramble to see which company will dominate the lucrative medical aesthetics product market, Mentor proposed a stock-for-stock merger in which Medicis stockholders would receive 0.62 shares of Mentor common stock for each Medicis share. Based on closing prices on Nov. 18. accessmylibrary.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next